Swanson Reed News

Concerns Over Consultation Process for R&D Tax Reform Bill

March 9th, 2020

A reform bill proposing controversial changes to the R&D Tax Incentive for FY20 is currently being considered by the Senate. This bill is a slightly modified version of a previous reform bill (Treasury Laws Amendment (Making Sure Multinationals Pay Their Fair Share of Tax in Australia and Other Measures) Bill 2018), which did not pass through the Senate last year. A Senate Economics Legislation Committee recommended in February 2019 that this bill should be deferred from consideration until further analysis […]

Read More

Application of R&D Tax Incentives to Software debated during Senate Select Committee of Financial Technology

March 2nd, 2020

Fintech Australia has used a speech at the the Senate Select Committee of Financial Technology and Regulatory Technology to call for better clarity that software activities be included within the scope of eligibility for R&D Tax Incentives. The Article reports a senior figure from ISA responding to the question “Would Atlassian be considered eligible for R&D tax incentives?” with a reply of “No, because it’s software”. We note however that this comment may be incorrect or out of context since: […]

Read More

Northern Minerals Announce That AusIndustry Have Set Aside Previous Finding That R&D Activities Were Not Eligible

February 25th, 2020

In May 2019, Northern Minerals (ASX: NTU) announced that the company had received notice of a finding that AusIndustry had deemed that the activities registered in the FY17 and FY18 periods related to activities that were “ineligible R&D activities”, which would not be eligible for the R&D tax offset in those income years. In June 2019, Northern Minerals subsequently announced that the company would exercise its review rights in relation to AusIndustry’s decision that the Company’s FY17 and FY18 R&D […]

Read More

CSL and Cochlear Call for Stability to R&D Tax Policy as Parliament Consider Proposed Reforms

February 24th, 2020

Over the past week, The Australian has featured articles quoting Australia’s two leading medical technology companies, CSL and Cochlear, calling on the Australian government to deliver consistent R&D Tax incentives after four years of policy review and uncertainty. The article comes at a time when Parliament and the Senate are again considering an R&D Tax Reform bill, which was not enacted as law during a previous attempt following concerns raised by the Senate Economics Committee, largely due to complexity of […]

Read More

Bryce Steele
Principal, Melbourne
Tel: (03) 9018 5778
Mob: 0435 713 493
Tom Parkhouse
Principal, Sydney
Tel: (02) 8006 0559
Mob: 0411 718 565
Andy Nguyen
Principal, Brisbane
Tel: (07) 3221 1499
Mob: 0407 750 249
Kieu McKellar
Manager, Adelaide
Tel: (08) 8121 7850
Mob: 0435 713 493
David Greatwich
Principal, Perth
Tel: (08) 9340 3745
Mob: 0468 386 250
Krishna Gungaram
Manager, Hobart
Tel: (03) 9018 5778
Mob: 0435 713 493

Categories

Archives

Email this job

[recaptcha]